feed,title,long_url,short_url
MedRxiv,"Comparative effectiveness of heterologous booster schedules with AZD1222, BNT162b2, or mRNA-1273 vaccines against COVID-19 during omicron predominance in the Nordic countries",https://medrxiv.org/cgi/content/short/2022.11.24.22282651v1?rss=1,https://bit.ly/3OSIfRq
